Tag: TGTX

TG Therapeutics has recently been granted three new patents by the United States Patent and Trademark Office (USPTO) for their ...

On February 5, 2024, Mayank Mamtani, an analyst at B. Riley Securities, expressed his optimistic view on TG Therapeutics (NASDAQ:TGTX). ...

TG Therapeutics (NYSE:TGTX) has experienced a notable decline in its short interest, with the percentage of float falling by 12.86% ...

TG Therapeutics is anticipating significant growth in its BRIUMVI U.S. net product revenue for the year 2024. Based on preliminary ...

TG Therapeutics (TGTX) has just released its preliminary U.S. BRIUMVI net product revenue figures for the fourth quarter of 2023 ...

In a surprising move, Barclays PLC has announced that it raised its stake in TG Therapeutics, Inc. by 11.3% during ...